Lotus's Generic Midostaurin Receives Approval in the U.S.
HYDERABAD: The family of Vangara Nagaraju, who were shocked at his sudden death, went to Bangalore on Wednesday and met the staff at Lotus Labs Pvt Ltd, where he was a subject of clinical trials. Nagaraju, of Nagampet village in Jammikuntla mandal of Karimnagar, had died at their residence on June 2.
Yet, Prakash did not follow international guidelines for testing – and the CROs that hired him didn’t require him to. He says that to earn more money he would participate in back-to-back trials on different drugs with gaps of only a few weeks or even a few days, instead of waiting the 90 days that the World Health Organization recommends.
Lotus Pharm`s Temozolomide approved in US an anti-cancer chemotherapy drug
Lotus` Generic Levonorgestrel (1.5Mg) Approved in US For Contraception